Weight Loss Drug Wegovy Expected
Sort by
172 items
Filter
Items per page
-
Ozempic and Wegovy Have Health Benefits Beyond Weight Loss
The effects of semaglutide drugs won’t just be cosmeticThe New York Times - Top stories -
How one state is trying to make weight loss drugs cheaper
Weight loss drugs aren't covered by insurance for North Carolina's state employees. The state is negotiating with drugmakers Eli Lilly and Novo Nordisk to try to lower the costs.NBC News - Top stories -
Sanders launches investigation into 'unacceptable' diabetes, weight loss drug prices
Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, on Wednesday launched an investigation into the “outrageously high prices” of Novo Nordisk’s respective diabetes and weight loss drugs, ...The Hill - Politics -
Insurers scale back reimbursements for drugs used for weight loss
A growing number of insurance carriers say they won't cover the cost of weight loss medications because it is too high. The change is forcing some patients to take desperate measures. NBC News' Erin McLaughlin reports.NBC News - Top stories -
What do weight loss drugs mean for a diet industry built on eating less and exercising more?
New weight loss drugs are reshaping a dieting industry built on eating less and exercising moreABC News - Health -
The best meal kits for weight loss and fitness-friendly eating
The best meal kits for weight loss make it easy (and fun!) to stick to a healthy, consistent diet.CBS News - Top stories -
Comcast earnings beat expectations as Peacock losses narrow
Comcast scored a profit beat for the latest quarter, and that seemed to be overshadowing another drop in broadband subscribers.MarketWatch - Business -
Gilead’s quarterly loss is narrower than expected
Gilead Sciences Inc.’s stock dipped 0.2% in after-hours trading Thursday, after the drug company’s adjusted first-quarter profit was narrower than expected.MarketWatch - Business -
Selling weight-loss and muscle-building supplements to minors in New York is now illegal
It's now illegal to sell weight-loss and muscle-building supplements to minors in New YorkABC News - Health - New York -
AbbVie’s first-quarter results top expectations as arthritis drugs fuel growth
AbbVie on Friday reported first-quarter results that beat expectations even as sales of its blockbuster autoimmune drug Humira continued to fall.MarketWatch - Business -
Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.
Before insurance, Novo Nordisk charges about $1,000 per month for Ozempic in the United States. In Germany, the company charges $59 per month for the same drug.CNBC - Business -
The New Drug Threat
An investigation into the supply of illegal synthetic opioid drugs called nitazenes.BBC News - Top stories -
-
Biden grants clemency to 16 nonviolent drug offenders
"America is a nation founded on the promise of second chances," President Biden said in a statement.CBS News - Politics - Joe Biden -
Biden grants clemency to 16 nonviolent drug offenders
"America is a nation founded on the promise of second chances," President Biden said in a statement.CBS News - Politics - Joe Biden -
Meta proves AI hype has its limits
Artificial intelligence is a multibillion-dollar project with no clear timeline for revenuesFinancial Times - Business - Meta -
Zuckerberg defends Meta’s AI spending spree as shares tumble
Parent of Facebook and Instagram reports better than expected quarterly revenue but raises capex guidanceFinancial Times - Business -
Zuckerberg defends Meta’s AI spending spree as shares tumble
Parent of Facebook and Instagram reports better than expected quarterly revenue but raises capex guidanceFinancial Times - Business -
EveryONE Medicines: Designing Drugs for Rare Diseases, One at a Time
Khosla Ventures, GV, Third Rock Ventures back effort to create medicines for individual patients with rare central nervous system diseases.The Wall Street Journal - World -
For Beaten-Down Maker of Alzheimer's Drug, Good Enough Will Do
In-line sales for Alzheimer’s drug Leqembi and a beat for rare-disease drug Skyclarys has Wall Street giving Biogen another chance.The Wall Street Journal - World -
BHP plans £31bn bid for Anglo American but attracts ire from South Africa and shareholders
Legal & General and Abrdn criticise offer as undervaluing UK-listed minerFinancial Times - Business -
Sanders locks onto next drug pricing target: Ozempic
Click in for more news from The Hill {beacon} Health Care Health Care The Big Story Sanders locks onto next drug pricing target: Ozempic After successfully getting manufacturers to lower the prices of insulin and inhalers, Sen. Bernie Sanders ...The Hill - Politics -
Angels dispute controversial review in loss to O's
Replay review of an initial out call on Jo Adell's attempted steal of second base with two outs in the bottom of the ninth inning was not overturned, resulting in the Angels' 6-5 loss to the Orioles.ESPN - Sports -
Stocks pare losses on Thursday with help of these bright spots
Semiconductors, carmakers and gains in other sectors helped limit stock-market losses on ThursdayMarketWatch - Business -
Is Myanmar's army reversing its losses? It's complicated
A rebel group that took a key town lost it to the junta two weeks later. But there's more to the story.BBC News - Top stories -
Meta proves AI hype has its limits
Artificial intelligence is a multibillion-dollar project with no clear timeline for revenuesFinancial Times - Business - Meta -
Meta proves AI hype has its limits
Artificial intelligence is a multibillion-dollar project with no clear timeline for revenuesFinancial Times - Business - Meta -
The colonialist overtones of EU’s green trade crusade
Many middle-income countries show reserves of pragmatic tolerance that Europeans do not necessarily deserveFinancial Times - Business -
Is Britain suffering from a ‘sick note culture’?
Rishi Sunak has vowed to get people back to work but data indicates problems with the diagnosis — and proposed solutionFinancial Times - Business - United Kingdom -
Meta proves AI hype has its limits
Artificial intelligence is a multibillion-dollar project with no clear timeline for revenuesFinancial Times - Business - Meta -
Southwest will limit hiring and drop 4 airports after loss. American Airlines posts 1Q loss as well
American and Southwest airlines both say they lost money in the first quarter, and they're responding by trying to cut costsABC News - Top stories - Travel -
U.S. Natural Gas Futures Lose Ground on Storage Surplus
U.S. natural gas futures added to the previous day’s losses as a weekly inventory report showed a larger-than-expected build in natural gas storage.The Wall Street Journal - World -
Microsoft’s cloud sales receive a boost from AI
Tech group’s shares up 3% a day after better than expected earnings reportFinancial Times - Business - Microsoft -
Anne Hathaway on ‘The Idea of You’ and Letting Go of Expectations
On the debut of ‘The Interview,' the actress talks to David Marchese about learning to let go of other people’s opinions.The New York Times - Top stories -
Ford stock rises as EV losses are held in check and hybrid sales surge
Carmaker reports a better-than-expected quarter, and EV losses were around Wall Street expectations.MarketWatch - Business -
Liverpool's Premier League title hopes hit by 2-0 loss to Everton. Man United survives another scare
It looks like there will be no dream send-off for Jurgen Klopp after a 2-0 loss at Everton dealt a major blow to Liverpool’s Premier League title hopesABC News - Sports - Premier League -
As Liverpool run out of steam, title hopes evaporate at Everton
It appears Jurgen Klopp's players have switched off as Wednesday's loss practically ends Liverpool's title hopes.ESPN - Sports -
Van Dijk questions desire of team-mates after loss
Liverpool captain Virgil van Dijk questions his side's desire to win the Premier League after a damaging defeat against Merseyside rivals Everton.BBC News - Top stories -
Meta's Reality Labs posts $3.85 billion loss in first quarter
Mark Zuckerberg's bet on the metaverse continues to be a money-bleeding endeavor, with the unit reporting billions of dollars in losses every quarter.CNBC - Business -
How a Loss in the Emergency Abortion Case Could Become a Win for Biden
A ruling in the emergency abortion case heard at the high court on Wednesday could turn out abortion rights supporters to the polls.The New York Times - Top stories - Joe Biden